Nuvelo(NUVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo(NUVO)

NUVO 0.170

+169,917.0%

Aug 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (108)	11/1/2006 6:20:57 PM
From: Arthur Radley	Read Replies (1) of 140

Nov 1 (Reuters) - Banc of America Securities on Wedesday began coverage of five biopharmaceutical companies and said Myriad Genetics Inc. (MYGN.O: Quote, Profile, Research) and Nuvelo Inc. (NUVO.O: Quote, Profile, Research) were among its top picks. BofA also assumed coverage of Acorda Therapeutics Inc. (ACOR.O: Quote, Profile, Research) and Acadia Pharmaceuticals Inc. (ACAD.O: Quote, Profile, Research). Following are the ratings and price targets of these companies. Rating Price target Myriad Genetics Inc. Buy $40 Nuvelo Inc. Buy $26 Keryx Biopharmaceuticals Inc. Buy $26 Array BioPharma Inc. Buy $13 Dendreon Corp. Neutral $6 Acorda Therapeutics Inc. Buy $24 Acadia Pharmaceuticals Inc. Buy $14 (

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next